Brain (and spinal cord) tumours
Results
Phase 1
This trial looked at olaparib for a type of brain tumour called a glioblastoma that had started to grow again after treatment. It was supported by Cancer Research UK.
Recruitment start: 18 July 2011
Recruitment end: 2 January 2017
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Anthony Chalmers
AstraZeneca
Cancer Research UK (Centre for Drug Development)
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
This is Cancer Research UK trial number CRUKD/11/006.
Last reviewed: 14 March 2018
CRUK internal database number: 5030
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
